GoKawiilResearch funding surges into long COVID and related post-infection syndromes
Scientists are accelerating efforts to understand why some infections trigger lasting illnesses such as long COVID and ME/CFS. A 2024 estimate put the global number of long COVID cases at 400 million, costing roughly $1 trillion annually, spurring governments including the US and Germany to commit over $1.7 billion combined toward research into post-infection diseases.
GoKawiil's interpretation of the reporting above, not reported fact.
Despite growing funding, researchers say the scale of investment still lags far behind the disease burden, leaving millions without clear diagnoses or treatments. Progress in identifying triggers and biomarkers for these syndromes could reshape how medicine treats chronic illness following common infections, not just COVID-19.
- Long COVID and similar chronic illnesses now affect an estimated 400 million people worldwide.
- The US and Germany have pledged over $1.7 billion combined for post-infection disease research.
- Researchers say funding remains insufficient relative to the disease's economic and human toll.
Wellue O2Ring Wearable Pulse Oximeter — For anyone tracking recovery after a viral illness, a continuous ring oximeter logs oxygen saturation and heart rate overnight instead of giving one fleeting fingertip reading. The Wellue O2Ring syncs data to your phone, so you can bring real trend charts to a doctor's appointment rather than relying on memory.
See Wellue O2Ring Wearable Pulse Oximeter on Amazon → Affiliate link — we may earn a commission on purchases, at no extra cost to you. Product picked by AI based on this article; it is not a tested recommendation.Source: nature.com — Makin, 2026-09-02
Published there as: “When do infections lead to long COVID? Scientists close in on triggers and treatments for post-viral syndromes”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.